$810 Million is the total value of Samsara BioCapital, LLC's 50 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 350.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GRPH | New | Graphite Bio Inc | $228,374,000 | – | 7,431,623 | +100.0% | 28.19% | – |
| TIL | Buy | Instil Bio Inc | $41,449,000 | +6.3% | 2,145,395 | +38.1% | 5.12% | -28.8% |
| CNTA | New | Centessa Pharmaceuticals PLCspons ads | $34,149,000 | – | 1,537,533 | +100.0% | 4.22% | – |
| RXRX | New | Recursion Pharmaceuticals Inc | $28,309,000 | – | 775,583 | +100.0% | 3.50% | – |
| RAIN | New | Rain Therapeutics Inc | $25,444,000 | – | 1,637,308 | +100.0% | 3.14% | – |
| JANX | New | Janux Therapeutics Inc. | $15,168,000 | – | 607,949 | +100.0% | 1.87% | – |
| ELEV | New | Elevation Oncology Inc | $12,650,000 | – | 932,239 | +100.0% | 1.56% | – |
| RYTM | Buy | Rhythm Pharmaceuticals Inc | $5,880,000 | +37.5% | 300,293 | +49.4% | 0.73% | -8.0% |
| DAWN | New | Day One Biopharmaceuticals | $4,611,000 | – | 202,500 | +100.0% | 0.57% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Intercept Pharmaceuticals Inc | 20 | Q3 2023 | 24.0% |
| ALLAKOS INC | 20 | Q3 2023 | 23.0% |
| SUTRO BIOPHARMA INC | 20 | Q3 2023 | 10.1% |
| SYROS PHARMACEUTICALS INC | 16 | Q3 2022 | 11.6% |
| ATRECA INC | 16 | Q1 2023 | 7.4% |
| IVERIC BIO INC | 15 | Q2 2023 | 5.5% |
| ACLARIS THERAPEUTICS INC | 15 | Q3 2023 | 4.8% |
| RHYTHM PHARMACEUTICALS INC | 15 | Q3 2023 | 2.4% |
| ODONATE THERAPEUTICS INC | 14 | Q1 2022 | 14.9% |
| SPRINGWORKS THERAPEUTICS INC | 14 | Q4 2022 | 12.1% |
View Samsara BioCapital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Samsara BioCapital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.